Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.21 · Revenue $1.64B · 11 analysts
Est. EPS $0.22 · Revenue $1.68B · 10 analysts
Est. EPS $0.81 · Revenue $6.59B · 9 analysts
Est. EPS $0.20 · Revenue $1.61B · 8 analysts
EPS $0.09 · Revenue $1.58B
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $6.6B | -3.4% | +7.0% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-530.2M | -174.5% | -12.0% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +32.7% | -2.8% | +0.2% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -3.8% | -123.5% | -1.0% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -8.1% | -177.2% | -17.8% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $495.0M | -28.5% | +457.9% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +7.6% | -25.9% | +421.4% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 70.9% | +4.1% | -3.8% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.78x | +66.2% | +1.3% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $11.8B | -2.6% | -0.6% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -0.78 vs 0.90 | -186.6% | 0.06 vs 0.21 | -71.2% |
| Revenue Surprise | $6.6B vs $6.5B | +0.4% | $1.7B vs $1.6B | +3.1% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Ligner Emmanuel | director, officer: President and CEO | Common Stock | D | 29,803 | $13.33 |
| Aug 14, 2026 | Hankamer Brittany | officer: EVP, Chief HR Officer | Common Stock | D | 181 | $13.66 |
| Jul 31, 2026 | Eck Steven W | officer: SVP & Chief Accounting Officer | Common Stock | D | 1,385 | $13.78 |
| Jul 24, 2026 | Sokenu Claudius | officer: EVP, Chief Legal & Compliance | Common Stock | D | 1,201 | $11.44 |
| Jun 21, 2026 | Walker Corey | officer: President, VWR Dist. & Servs. | Common Stock | D | 3,010 | $9.58 |
Operator : Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Avantor's Second Quarter 2026 Earnings Conference Call. I would now like to turn the conference over to Chris Fidyk, Vice President of Investor Relations. Chris, you may begin. Chris Fidyk : Thank you, operator. Good morning, everyone, and thank you for joining us. Our speakers today are Emmanuel Ligner, President and Chief Executive Officer; and Steve Eck, the Senior Vice President, Interim Chief Financial Officer and Chief Accounting Officer. The press release and our presentation accompanying this call are available on our Investor Relations website at ir.avantorsciences.com. Following our prepared remarks, we will open the call for questions. A replay of the call will be made available on our website later today. During this call, we will make forward-looking statements within the meaning of the U.S. federal securities laws, including statements regarding events or developments that we believe or anticipate may occur in the future. These forward-looking statements are subject to a number of risks and uncertainties, including those set forth in our SEC filings. Actual results may differ materially from any forward-looking statements that we make today. These forward-looking statements speak only as of the date they are made. We do not assume any obligation to update these forward-looking statements as a result of new information, future events or other developments. This call will include a discussion of non-GAAP measures. A reconciliation of these non-GAAP measures can be found in the press release and in the supplemental disclosure package on our Investor Relations website. I will now turn the call over to Emmanuel. Emmanuel Ligner : Thank you, Chris, and good morning, everyone. Thank you for joining our call today. I will begin with a high-level update on our second quarter performance. I will then reflect on the actions we've taken since I came into this role nearly 12 months ago and discuss the progress we are making in executing Revival, our comprehensive program to sharpen strategic focus and improve execution. Turning to Slide 4. Let me highlight a few key messages. First, we remain highly focused on executing Revival, and I am very happy with the progress we made to date. Revival delivered measurable results and put us on a path to sustainable growth. Second, I'm pleased that our second quarter results exceeded expectations across several key financial metrics. Those results were driven by improved performance in our VWR distribution and service segments which returned to positive organic revenue growth during the quarter. Our Bioscience & Medtech Products segments performed near the high end of our expectation and is positioned to return to growth in the second half. Third, we delivered excellent free cash flow, enabling us to invest in the business while also paying down debt. We remain …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Corey D. Walker | President of Laboratory Solutions | USD 1,064,060 | Male | 1978 | Active |
Emmanuel Ligner | President, Chief Executive Officer & Director | USD 895,636 | Male | 1971 | Active |
Michael Wondrasch | Executive Vice President & Chief Information Officer | USD 808,631 | Male | 1969 | Active |
Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal & Compliance Officer | USD 798,629 | Male | 1968 | Active |
Benoit Gourdier | Executive Vice President of Bioscience Production | USD 796,003 | Male | 1967 | Active |
Brittany Hankamer | Executive Vice President & Chief Human Resources Officer | — | Female | 1971 | Active |
Steven W. Eck | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | — | Male | 1976 | Active |
Chris Fidyk | Vice President of Investor Relations | — | Male | — | Active |
Christophe Couturier | Executive Vice President of AMEA | — | Male | 1966 | Active |
Mary Blenn | Executive Vice President & Chief Operating Officer | — | Female | — | Active |
Advisors Capital Management LLC purchased a new position in shares of Avantor, Inc. (NYSE: AVTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 441,317 shares of the company's stock, valued at approximately $4,369,000. Advisors Capital Management LLC owned about 0.07% of
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Here is how Avantor, Inc. (AVTR) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Bank of Nova Scotia cut its stake in Avantor, Inc. (NYSE: AVTR) by 67.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 41,600 shares of the company's stock after selling 84,322 shares during the quarter. Bank of Nova
